Search clinical trials for: WCK 5222

Total 311 results

Wockhardt
Quintiles, Inc.

Completed

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

Serious Gram-negative Infections

United States
Wockhardt
Clinartis

Completed

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

Renal Impairment

United States
Wockhardt
Clinartis

Completed

Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects

Intrapulmonary Pharmacokinetics of WCK 2349

United States
Wockhardt

Completed

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

QT/QTc Interval in Healthy Volunteers

United States
Wockhardt

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

Pharmacokinetics
Wockhardt

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

Bioavailability

United States
Wockhardt
Quintiles, Inc.

Completed

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Healthy Subjects

United States
Dong-A ST Co., Ltd.

Not yet recruiting

Phase III Clinical Trial of DA-5212 in Patients With Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

Early Rheumatoid Arthritis

China
University of Lausanne Hospitals

Completed

Safety and Cost-effectiveness Study of Single Port Laparoscopic Cholecystectomies (SPoCOT)

Cholecystolithiasis

Switzerland
Dong-A ST Co., Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
Zoll Medical Corporation

Completed

Heart Sounds Registry (HEARIT-Reg)

Heart Failure; With Decompensation

United States, Austria, Germany, Poland
Wockhardt
Quintiles, Inc.

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime

Healthy

United States
AbbVie

Completed

A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222

Cystic Fibrosis

United States, Belgium, Canada, Czechia, France, Hungary, Netherlands, New Zealand, Poland, Slovakia, United Kingdom, Serbia
American Institute for Cancer Research

Completed

Testing the Effectiveness of Coping With Cancer in the Kitchen (CCK)

Cancer | Nutrition Aspect of Cancer

United States
Esanex Inc.

Completed

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Cancer

United States
Esanex Inc.

Completed

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies

Cancer
Esanex Inc.
Pfizer; Serenex, Inc.

Completed

Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies

Cancer

United States
Esanex Inc.

Terminated

Study of SNX-5422 in TP53 Null Cancers

Cancer

United States
National Cancer Institute (NCI)

Completed

SNX-5422 to Treat Solid Tumor Cancers and Lymphomas

Neoplasms | Lymphoma

United States
Esanex Inc.
Serenex, Inc.

Completed

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

Hematologic Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Bacterial Infection

United States
Second Xiangya Hospital of Central South University

Completed

Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass

Osteoporosis, Osteopenia

China
Theravance Biopharma

Completed

Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects

Healthy

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects

Osteoporosis

China
University of Illinois at Chicago
Northwestern University; Northeastern Illinois University

Not yet recruiting

WeCanManage. An mHealth Self-management Tool

Sarcoma | Breast Cancer | Head and Neck Cancer
Teijin America, Inc.
Parexel

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Children's Healthcare of Atlanta

Withdrawn

Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?

Postoperative Wound Infection

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Multiple Dose Study to Evaluate the Effect of SHR-1222 Injection in Postmenopausal Osteoporosis Patients

Osteoporosis

China
Reinier Haga Orthopedisch Centrum

Not yet recruiting

RSA Restoris MultiCompartmental Knee

Osteoarthritis, Knee
Blood Purification Technologies, Inc.
University of Washington; Wearable Artificial Kidney Foundation

Completed

24 Hour Use of the Wearable Artificial Kidney (WAK US 1)

End Stage Renal Disease

United States
Wockhardt

Completed

Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment

Hepatic Impairment

United States
Organon and Co

Completed

To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)

Schizophrenia
Venatorx Pharmaceuticals, Inc.
National Institutes of Health (NIH)

Completed

VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment

Pharmacokinetics

United States
Alaska Blind Child Discovery

Completed

Hyperopia Detection GCK With Glow Fixation

Accommodation Disorder | Hyperopia of Both Eyes | Astigmatism Bilateral | Amblyopia Bilateral

United States
Esanex Inc.

Terminated

Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL

Cancer

United States
Esanex Inc.
National Cancer Institute (NCI)

Completed

Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas

Lymphoma | Leukemia | Solid Tumor Malignancy | Lymphoid Malignancy (Lymphoma and CLL)

United States
MedImmune LLC

Completed

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

Cancer

France
Maxx Orthopedics Inc

Recruiting

Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship

Bone Loss | Periprosthetic Fractures | Infection | Aseptic Loosening | MCL - Medial Collateral Ligament Rupture of the Knee

United States
The University of Texas Health Science Center,...
Robert Cizik Eye Clinic

Terminated

Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period

Glaucoma

United States
Merck Sharp & Dohme LLC

Completed

A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

Psoriasis
Esanex Inc.

Terminated

Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers

Cancer

United States
AbbVie

Completed

A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor (M23-492 FE)

Healthy Volunteers

United States
Rasmia Elgohary

Not yet recruiting

Evaluation of the Effect of Wet Cupping (Hijama) on Primary Fibromyalgia

Treatment
Zoll Medical Corporation

Terminated

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study (WED-HED)

Sudden Cardiac Death | Sudden Cardiac Arrest

United States
Texas Tech University Health Sciences Center

Terminated

Ultrasound for Diagnosis of Biliary Dyskinesia

Biliary Dyskinesia

United States
Zoll Medical Corporation
University of Rochester

Completed

LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry (WEARIT-III)

Ischemic Heart Failure

United States
Vertex Pharmaceuticals Incorporated

Completed

Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

Hepatitis C

New Zealand
Esanex Inc.

Completed

Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors

Cancer

United States
Esanex Inc.

Completed

Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors

Cancer

United States

3

Subscribe